Beyond access: improving real-world naloxone use to address the opioid overdose epidemic.  Neuenschwander J, Wilkerson RG, Weiner SG.  Int J Emerg Med. 2026 Jun 4;19(1):152. doi: 10.1186/s12245-026-01261-7. PMID: 42243669; PMCID: PMC1323…

Reframing Buprenorphine as a Pharmacologic Modifier of Opioid-Induced Respiratory Depression in the Fentanyl Era.  Bahji A, Ghauri I, Mathew N, Day N, Tanguay R.  Pharmaceuticals (Basel). 2026 May 20;19(5):799. doi: 10.3390/ph19050799. P…

Commentary on Comstock et al.: Here we go again—Kratom and the failure to learn from the opioid crisis.  Kolodny, A. (2026),  Addiction. doi.org/10.1111/add.70512 https://onlinelibrary.wiley.com/doi/full/10.1111/add.70512

Analytically Confirmed Opioid Detections From the Emerging Drugs Network of Australia.  Soderstrom J, Weber C, Greene S, Isoardi K, Alfred S, Tran V, Stockham P, Schumann J, Thompson A, Fatovich D; EDNA Investigators.  Emerg Med Australa…

EUDA initial report on the new psychoactive substance spirochlorphine Introduction 8-[1-(4-Chlorophenyl)ethyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, commonly known as spirochlorphine, is a spirotriazole and a synthetic opioid belonging to th…

EUDA initial report on the new psychoactive substance cychlorphine Introduction 3-(3-{1-[1-(4-Chlorophenyl)ethyl]piperidin-4-yl}-2-oxo-2,3-dihydro-1H-1,3-benzimidazol-1-yl)propanenitrile, commonly known as cychlorphine, is a piperidine benzimidazo…